CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in EXEL — Exelixis, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,065,407
+$23,636,265 QoQ
Shares Held
2,261,816
-2.4% QoQ
Ownership
0.913%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#24
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. EXEL ranks #13 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,065,407 | 2,261,816 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $99,429,142 | 2,318,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $98,031,843 | 2,236,638 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $92,917,029 | 2,249,807 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $142,646,186 | 3,236,075 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $122,626,346 | 3,321,407 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $108,303,354 | 3,252,353 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $84,950,439 | 3,273,620 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $74,301,346 | 3,306,691 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $79,937,471 | 3,368,625 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $80,713,875 | 3,364,480 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $72,883,734 | 3,335,640 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $62,629,585 | 3,277,320 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $62,846,649 | 3,237,849 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $54,226,460 | 3,380,702 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $51,149,759 | 3,262,102 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $63,579,970 | 3,053,793 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $66,937,777 | 2,952,703 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $49,525,090 | 2,709,250 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $54,092,186 | 2,558,760 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $30,637,421 | 1,681,527 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $35,827,943 | 1,586,009 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $30,822,944 | 1,535,772 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $37,022,263 | 1,514,203 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $35,338,960 | 1,488,583 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $24,967,846 | 1,449,933 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||